2020 Roche Performance, Capabilities, Goals and Strategies
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
Roche: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
US$ 1,520.00
October 2010
112 pages
2020 Roche: US, Europe, Japan-Diagnostics Market Shares and Competitive Position by Product and Country-Performance, Capabilities, Goals and Strategies
US$ 2,450.00
September 2020
128 pages
2018 Pharmaceutical Competitive Intelligence: Celgene Performance, Capabilities, Goals and Strategies
US$ 950.00
November 2018
-
2020 Exelixis Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
2020 Gilead Sciences Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
